Revenue
0 USD
2014 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
14 filing records in this dataset, filed from 2011-07-13 to 2014-10-02. Reported financial figures are available; chart coverage varies by period.
0 USD
2014 Q3 · USD
-103 thousand USD
2014 Q3 · USD
-103 thousand USD
2014 Q3 · USD
35942913 shares
26.20% · 7.46 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-868 thousand USD
2013-03-01 – 2014-02-28
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2014-10-02.
Financial data available through: 2013-05-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 625,586
–
Current period
−USD 755,868
–
-755868 − -625586 = -130282 USD
-625586 USD · 2011-06-01 – 2012-05-31
Inspect prior input Prior source-755868 USD · 2012-06-01 – 2013-05-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 625,330
–
Current period
−USD 692,311
–
-692311 − -625330 = -66981 USD
-625330 USD · 2011-06-01 – 2012-05-31
Inspect prior input Prior source-692311 USD · 2012-06-01 – 2013-05-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 4,866
–
Current period
USD 0
–
0 − 4866 = -4866 USD
4866 USD · 2011-06-01 – 2012-05-31
Inspect prior input Prior source0 USD · 2012-06-01 – 2013-05-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value | Source evidence |
|---|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|
Cash generated by the company’s normal business operations.
| Period | Series | Value | Source evidence |
|---|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2012 2011-06-01 – 2012-05-31 | −USD 625,586 Exact valueExact value: -625586 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 625,330 Exact valueExact value: -625330 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,866 Exact valueExact value: 4866 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 630,196 Calculation and evidence-625330 − 4866 USD Exact free cash flow: -630196 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2013 2012-06-01 – 2013-05-31 | −USD 755,868 Exact valueExact value: -755868 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 692,311 Exact valueExact value: -692311 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 692,311 Calculation and evidence-692311 − 0 USD Exact free cash flow: -692311 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
14 filings · 828 latest values · 829 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001521065, 1521065, DSOL, dmax, edgar:1521065
Also known as DILMAX CORP., DILMAX CORP. , Drug Free Solution, Inc., Living Breath Project, Inc.